Cantor Fitzgerald Forecasts ACAD FY2026 Earnings
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for ACADIA Pharmaceuticals in a research report issued on Monday, June 9th. Cantor Fitzgerald analyst J. Kim anticipates that the biopharmaceutical company will post earnings of $0.85 per share for the year. Cantor Fitzgerald has a “Strong-Buy” rating […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for ACADIA Pharmaceuticals in a research report issued on Monday, June 9th. Cantor Fitzgerald analyst J. Kim anticipates that the biopharmaceutical company will post earnings of $0.85 per share for the year. Cantor Fitzgerald has a “Strong-Buy” rating […]
